Survival.

(A) The 2-year EFS of patients who received PBPCs (---) was 50% versus 39% of those who received BM grafts (—) (P = .20). (B) The 2-year OS was 58% in the PBPC group (---) versus 49% in the BM group (—) (P = .40). (C) Patients with intermediate-2 or high IPSS scores had a 2-year EFS of 57% with PBPC (---) versus 36% with BM (—) (P = .15). (D) Patients with intermediate-2 or high IPSS scores had a 2-year OS of 61% with PBPCs (---) versus 46% with BM (—) (P = .13).